Análisis coste-beneficio del uso de espironolactona en el tratamiento de la insuficiencia cardíaca crónica
- 1 January 2001
- journal article
- Published by Elsevier in Revista Espanola de Cardiologia
- Vol. 54 (2) , 175-180
- https://doi.org/10.1016/s0300-8932(01)76288-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Tendencias de la morbimortalidad por insuficiencia cardíaca en CataluñaRevista Espanola de Cardiologia, 1998
- La prevención primordial y el control poblacional de la insuficiencia cardíacaRevista Espanola de Cardiologia, 1998
- Trends in hospitalization and mortality for heart failure in Spain, 1980-1993European Heart Journal, 1997
- Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patientsCardiovascular Research, 1997
- Survival after the onset of congestive heart failure in Framingham Heart Study subjects.Circulation, 1993
- Evidence of a Partial Escape of Renin‐Angiotensin‐Aldosterone Blockade in Patients with Acute Myocardial Infarction Treated with Ace InhibitorsThe Journal of Clinical Pharmacology, 1993
- Aldosterone and antialdosterone therapy in congestive heart failureThe American Journal of Cardiology, 1993
- Epidemiology of heart failureAmerican Heart Journal, 1991
- Early Readmission of Elderly Patients With Congestive Heart FailureJournal of the American Geriatrics Society, 1990
- Functional Status and Well-being of Patients With Chronic ConditionsJAMA, 1989